The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 7 rounds in the feed, most often at Series A and in Defense.
We invest in only two kinds of technologies: those that move us toward utopia, and those that hold the line against oblivion.
Venture capitalblueyard.comRounds from 2020-06-13 to 2026-10-12
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Dubsof Dubsof turns a company’s scattered records into one system built around how it works, and runs it for them. | Seed Verified against 4 of 8 sources | $6.5M | 2026-10-12 | [ LEAD ] |
Castelion A hypersonic missile company | Series B Verified against 1 source |
| $350M |
| 2025-12-05 |
| [ PART ] |
Castelion A hypersonic missile company | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2025-01-29 | [ PART ] |
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2024-12-16 | [ PART ] |
Castelion A hypersonic missile company | Seed Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $14.2M | 2023-10-05 | [ PART ] |
Chemify A company at the intersection of AI, robotics and medicine | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $43M | 2023-08-03 | [ PART ] |
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Series A Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $41.5M | 2020-06-13 | [ PART ] |